Oneness Biotech Co Ltd Total Liabilities
Oneness Biotech Co Ltd total liabilities. Based on the latest financial reports, Oneness Biotech Co Ltd (4743) has total liabilities worth NT$872.67 Million TWD (≈ $27.49 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4743 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Oneness Biotech Co Ltd (2009–2025)
Total liabilities of Oneness Biotech Co Ltd from 2009 to 2025. This chart illustrates how Oneness Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Oneness Biotech Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Oneness Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Oneness Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Zhenjiang New Energy Equipment Co Ltd Class A
SHG:603507
|
China | CN¥6.69 Billion |
|
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
STU:2TZ
|
Germany | €2.91 Billion |
|
Beijing E Hualu Info Tech
SHE:300212
|
China | CN¥9.30 Billion |
|
JBG SMITH Properties
NYSE:JBGS
|
USA | $2.70 Billion |
|
Sapphire Foods India Limited
NSE:SAPPHIRE
|
India | Rs18.67 Billion |
|
Zhongsheng Group Holdings Limited
F:5Z0
|
Germany | €60.19 Billion |
|
Arctech Solar Holding Co Ltd
SHG:688408
|
China | CN¥7.99 Billion |
|
Guangdong Champion Asia Electronics Co Ltd
SHG:603386
|
China | CN¥2.42 Billion |
Liability Composition Analysis (2009–2025)
This chart breaks down Oneness Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 4743 total asset value.
Liquidity & Leverage Metrics
Oneness Biotech Co Ltd Total Liabilities Ratios Explained
Oneness Biotech Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 37.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oneness Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oneness Biotech Co Ltd (2009–2025)
The table below shows the annual total liabilities of Oneness Biotech Co Ltd from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.26 Billion ≈ $39.58 Million |
+46.16% |
| 2024-12-31 | NT$859.65 Million ≈ $27.08 Million |
-0.78% |
| 2023-12-31 | NT$866.43 Million ≈ $27.30 Million |
+23.71% |
| 2022-12-31 | NT$700.38 Million ≈ $22.07 Million |
-57.34% |
| 2021-12-31 | NT$1.64 Billion ≈ $51.72 Million |
+1.05% |
| 2020-12-31 | NT$1.62 Billion ≈ $51.18 Million |
+211.85% |
| 2019-12-31 | NT$520.96 Million ≈ $16.41 Million |
+207.09% |
| 2018-12-31 | NT$169.64 Million ≈ $5.34 Million |
+541.03% |
| 2017-12-31 | NT$26.46 Million ≈ $833.76K |
-15.74% |
| 2016-12-31 | NT$31.41 Million ≈ $989.49K |
-24.71% |
| 2015-12-31 | NT$41.72 Million ≈ $1.31 Million |
-47.77% |
| 2014-12-31 | NT$79.87 Million ≈ $2.52 Million |
-35.50% |
| 2013-12-31 | NT$123.82 Million ≈ $3.90 Million |
+478.35% |
| 2012-12-31 | NT$21.41 Million ≈ $674.50K |
+6.59% |
| 2011-12-31 | NT$20.09 Million ≈ $632.79K |
+7.72% |
| 2010-12-31 | NT$18.64 Million ≈ $587.42K |
+176.39% |
| 2009-12-31 | NT$6.75 Million ≈ $212.54K |
-- |
About Oneness Biotech Co Ltd
Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation and Organic Food segments. The company offers Fespixon which is a treatment of diabetic foot ulcer; and Bonvadis, a wound care medical device. It also develops FB825, whic… Read more